Causalus

Causalus

Causalus develops digital therapeutics services for rational medication. We help you find the safest medication balance

Founded 2018 Finland

Finland 11-50 employees Pre-Seed Total: $250.00K Health Care, Medical Devices +2

Causalus is a Finland-based startup founded in 2018, focusing on tackling the challenges associated with polypharmacy. The company's slogan "Causalus develops digital therapeutics services for rational medication. We help you find the safest medication balance" reflects its commitment to optimizing medication management. Causalus offers digital therapeutics software accompanied by remote clinic services, aimed at streamlining the review, monitoring, and standardization of complex medications. This approach not only minimizes harmful adverse effects but also maximizes the benefits, significantly improving patient health and well-being. The startup operates in the Health Care, Pharmaceutical, and SaaS industries and has received a Pre Seed Round investment of €250.00K on 01 January 2019 from Icebreaker.vc. Its innovative solution presents value across multiple levels by enhancing patient outcomes, optimizing resource allocation for healthcare professionals, and generating substantial savings for healthcare service providers, municipalities, and societies. Causalus's efforts not only address a critical issue within the healthcare sector but also demonstrate promising potential for investors seeking impactful opportunities in the digital therapeutics space.

Funding Stage	Amount	Investors	Lead Investors	Date
Pre Seed Round	€250.00K	1	Icebreaker.vc	01 Jan 2019

Funding Stage

Amount

Investors

Lead Investors

Date

Pre Seed Round

€250.00K

Icebreaker.vc

01 Jan 2019

FAQ About Causalus

Causalus develops digital therapeutics services for rational medication. We help you find the safest medication balance

Causalus was founded in 2018.

Causalus is headquartered in Finland.

Causalus operates in Health Care, Medical Devices, Pharmaceutical and SaaS. Its work centres on medication management, elderly care, patient safety and therapeutic optimization.

Causalus has approximately 11-50 employees.

Causalus has completed 1 funding round, raising a total of $250.00K. The latest funding stage is Pre-Seed.

Top alternatives and competitors to Causalus include AceAge, hellomed, Evondos Group, Ciegus Ltd Oy, Sabal Medical, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Causalus and AceAge are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Causalus

Funding Rounds & Investors (1)

Causalus Alternatives & Competitors

FAQ About Causalus